Research


Crystal Structure of Rhodopsin Mapped for First Time

Protein Crucial to Every Physiological Process

Dr. Krzystof Palczewski, Bishop Professor of Ophthalmology, and a team of UW researchers and their international colleagues have mapped the first crystal structure of a G protein-coupled receptor (GPCR). The GPCR is rhodopsin, one of a family of proteins crucial to everything from vision to embryonic development.

In phototransduction, a process critical to carrying out the first steps of vision, rhodopsin absorbs proteins inside the cell membranes of retinal rod cells. Phototransduction is the action of converting the body’s sensing of light into a nerve signal to the brain. Understanding rhodopsin helps investigators understand all GPCRs by giving them computational models for deciphering how other GPCRs function. GPCRs are one of the largest families—comprising some 3 percent—of proteins encoded in the human genome.

GPCRs, for example, are involved in receptors in the tongue and nose that are responsible for the senses of taste and smell. They are involved in regulation of the heartbeat, and even in opiate receptors in the brain that cause drug addiction.

Eye patient examination

A patient undergoes an eye exam. Research on phototransduction the physiological steps leading to sight—may result in improved vision care.

Palczewski said that the rhodopsin map will guide investigators in future experiments on how other receptors work. Dr. Tetsuji Okada, a postdoctoral fellow in Palczewski’s lab who initiated the project, spent long hours working in the dark to crystallize rhodopsin from bovine rod cells. Darkness was essential because light exposure changes the protein.

Pharmacologists target GPCRs for many conditions. Researchers hope that the newly acquired structural information may lead to advances in drug design for conditions ranging from vision problems to drug addiction and depression. Besides being the first, rhodopsin is one of only about 10 membrane proteins mapped in such detail. These findings were reported in the Aug. 4, 2000, issue of Science magazine.

Many older Americans suffer from macular degeneration, the leading cause of legal blindness for adults over 55 years of age. Jim Lea wanted to have an impact on macular degeneration research. Jim and Jane Lea gave generously to the UW Academic Medical Center this year to establish a fund that will build on the discovery of the crystal structure of rhodopsin.



©2001-2002, University of Washington Academic Medical Center. All rights reserved. Please honor our copyrights.